BBHC
TMDX icon

Brown Brothers Harriman & Co’s Transmedics TMDX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80
Closed -$7.95K – 1883
2026
Q1 		$7.95K Buy
80
+5
+7% +$652 ﹤0.01% 1399
2025
Q4 		$9.12K Buy
75
+51
+213% +$6.4K ﹤0.01% 1356
2025
Q3 		$2.69K Hold
24
– – ﹤0.01% 1535
2025
Q2 		$3.22K Buy
+24
New +$2.63K ﹤0.01% 1342
2022
Q2 		– Sell
-200
Closed -$5K – 1414
2022
Q1 		$5K Buy
+200
New +$3.58K ﹤0.01% 1128

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Brown Brothers Harriman & Co's TMDX Position: Q2 2026 in Review

Brown Brothers Harriman & Co sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 80 shares — an estimated $7.95K sold.

Brown Brothers Harriman & Co first reported a position in TMDX in Q1 2022 and held it in 5 quarters. The position peaked at $9.12K in Q4 2025. 373 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Brown Brothers Harriman & Co reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 80 Transmedics shares in Q2 2026, an estimated $7.95K.
  • Brown Brothers Harriman & Co first reported a position in Transmedics in Q1 2022 and held it in 5 quarters.
  • Brown Brothers Harriman & Co's Transmedics position peaked at $9.12K in Q4 2025.
  • 373 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.